-
Access Disparities in Maintenance Medication among Patients with Mild Asthma
Mar 10, 2025, 14:00 PM -
A Systematic Literature Review on Symptom Burden and Impact of Disease on Quality of Life in Patients With Essential Thrombocythemia
Mar 10, 2025, 14:00 PM -
The Cost-Effectiveness of Eteplirsen vs. Standard of Care in Delaying the Progression of Duchenne Muscular Dystrophy
Mar 10, 2025, 14:00 PM -
Development of a Conceptual Model of the Patient Experience with Idiopathic Hypersomnia: Patient Interviews from a Clinical Trial (NCT05156047)
Mar 10, 2025, 14:00 PM -
Co-Design of a Discrete Choice Experiment for Revascularization Decisions in Complex Coronary Heart Disease: Importance of Patient Perspectives
Mar 10, 2025, 14:00 PM -
An Evaluation of PhlexNeuron, an Internal, Proprietary Artificial Intelligence (AI) Tool for Systematic Literature Review (SLR) Screening
Mar 10, 2025, 14:00 PM -
Insight into Approvals, Marketing, and Pricing of New Medicines 2018 to 2022
Mar 10, 2025, 14:00 PM -
Association between Polypharmacy and Cognitive Limitations among Adults with Depression in the United States
Mar 10, 2025, 14:00 PM -
Inequities in Access to Oncology Drugs in Brazil - the Case of Public and Private Healthcare Systems
Mar 10, 2025, 14:00 PM -
The Burden of Migraine in Brazil's Private Healthcare System: Results From the Brazil Migraine Real-World Evidence (BREM) Study
Mar 10, 2025, 14:00 PM -
Broadening the Scope of Value: Evaluating Payer Perspectives and Insights on ICER's Latest Initiatives and Tools
Mar 10, 2025, 14:00 PM -
Association Between Initiation of ENDS and Cigarette Smoking Reduction: A Causal Time Zero Approach to the PATH Study
Mar 10, 2025, 14:00 PM -
Do Breakthrough Therapies Demonstrate Breakthrough Value to Payers? An Evaluation of US Hemophilia B Gene Therapy Access Policies
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns and Clinical Characteristics Among Patients With Crohn’s Disease Receiving First- and Second-Line Biologic Treatments in The United States
Mar 10, 2025, 14:00 PM -
Cost-Benefit Evaluation of Containers in the Central Sterile Services Department (CSSD)
Mar 10, 2025, 14:00 PM -
Therapeutic Options for Changing the Course of Disease in Generalized Myasthenia Gravis (gMG) and Fiscal Consequences for the Canadian Governments
Mar 10, 2025, 14:00 PM -
Broadening the Evidence Base: Incorporating Environmental Considerations Into HTAs
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization and the Economic Burden of Neovascular Age-Related Macular Degeneration (nAMD): A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Balancing Vulnerability and Freedom: Perspectives on HIV Cure-Related Trials With Analytical Treatment Interruption Among People With HIV and Healthcare Practitioners in the United States
Mar 10, 2025, 14:00 PM -
Anemia-Related Survival of Patients with Myelofibrosis: A Retrospective Real-World Study
Mar 10, 2025, 14:00 PM
